Evidence map›Paper›PMID 40343672›Full record

SynthesisNeuropsychology review2026

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.

Juan Manuel Villalpando, Bernard-Simon Leclerc, Minh Tri Le, Carol Hudon, Aline Bolduc, Marie-Jeanne Kergoat, Consortium for the Early Identification of Alzheimer’s Disease-Quebec (CIMA-Q)

Abstract readSystematic ReviewComparative Study
In one paragraph

Synthesis in Neuropsychology review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juan Manuel VillalpandoCentre de recherche de l'Institut universitaire de gériatrie de Montréal (IUGM), Centre intégré universitaire de santé et de services Sociaux (CIUSSS) du Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada.
Bernard-Simon LeclercCentre de recherche de l'Institut universitaire de gériatrie de Montréal (IUGM), Centre intégré universitaire de santé et de services Sociaux (CIUSSS) du Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada. bs.leclerc@umontreal.ca.ORCID http://orcid.org/0009-0007-1386-7411
Minh Tri LeFaculté de Médecine, Université de Montréal, Montréal, Canada.
Carol HudonÉcole de Psychologie, Université Laval, Québec, Canada.
Aline BolducCentre de recherche de l'Institut universitaire de gériatrie de Montréal (IUGM), Centre intégré universitaire de santé et de services Sociaux (CIUSSS) du Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada.
Marie-Jeanne KergoatCentre de recherche de l'Institut universitaire de gériatrie de Montréal (IUGM), Centre intégré universitaire de santé et de services Sociaux (CIUSSS) du Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada.
Consortium for the Early Identification of Alzheimer’s Disease-Quebec (CIMA-Q)

Funding

Consortium for the Early Identification of Alzheimer's Disease-Quebec Unknown
6 · The paper itself

Abstract

Alzheimer's is a progressive disease, with a long preclinical phase of many decades. Accurate classification within longitudinal cohort studies is crucial for understanding disease progression and for the comparability and collaboration across studies. The main objective of this systematic review was to identify and compare the diagnostic criteria used in prospective population study cohorts centering on the Alzheimer's disease clinical continuum in older adults. A review was performed of cohort studies started in the year 2000 or later, with a follow-up duration of at least 3 years among people aged between 50 and 85 years old living in the community. Original studies were searched in MEDLINE, Embase, Cochrane, PsycINFO, and Web of Science. Two independent reviewers agreed on the final selection of 28 studies covering 25 cohorts. One study was identified by three independent judges as having methodological limitations due to inadequate reporting as per the modified NIH quality assessment tool. Data was extracted from each included study using a standardized extraction form. In general, the studies followed fewer than 1500 participants. The results showed convergence in the choice of diagnostic classification criteria among the 25 cohorts studied especially for the later stages of AD, while criteria for the earliest stages showed greater variability. Only five cohorts studied were concerned with the follow-up of the full spectrum of the disease. Our study may help to put in place a unified set of clinical diagnostic criteria across the continuum of Alzheimer's disease, rather than criteria developed specifically for a given study.

Indexed as

Alzheimer DiseaseCohort StudiesDisease ProgressionHumansLongitudinal StudiesAlzheimer’s diseaseCognitive testsCohort studiesDiagnosisMild cognitive impairmentSystematic review

Identifiers

PMID40343672
PMCPMC13279743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.